Expired contract

Framework for the Ongoing Supply of Nucleotides

Details

Supplier(s)
Thermo Fisher Scientific Baltics UAB, Larova GmbH, HFA Healthcare Limited
Value
£1,000,000
Duration
3 years
Topic
Chemical products
Published
9 February 2021

Tender description

In response to the COVID-19 Vaccine manufacture programme, CPI need to secure supply of Nucleotides tohelp develop a self-amplifying RNA Vaccine. For more information please see the tender documents at https://ne1procurementservices.com/

Timeline

  1. Completed: Award date22 January 2021
  2. Completed: Award published9 February 2021
    Current notice
  3. Completed: Contract expiry date5 July 2024

About the buyer

Centre for Process Innovation buys as a public sector innovation and technology organisation, and is a founding partner in the High Value Manufacturing Catapult network. Ten innovation centres across North East England and Scotland carry out its research and development work. European and UK government programmes fund its work, including the European Regional Development Fund. Facilities, expertise and funder networks help businesses develop, test and scale new products.

Over the past 5 years, most of Centre for Process Innovation's contract awards have been in laboratory and precision equipment, IT services and repair and maintenance.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

19 similar open tenders

See more open tenders related to Chemical products.

Explore all open tenders

Finding public sector work shouldn't be hard

Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.